NDC 0069-0400-01 - Zithromax
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0069-0400
- Requested NDC
- 0069-0400-01
- Package NDCs from labels
- 0069-0400-01, 0069-0400-10
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company
- Effective date
- 2026-09-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zithromax | Pfizer Laboratories Div Pfizer Inc | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | 2026-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0069-0400-01 | Zithromax | 5 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 5 | 25 | |
| 0069-0400-10 | Zithromax | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 25 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0069-0400 | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 25 | Current NDC, Legacy NDC, 2 package rows | 20250212_8d24bacb-feff-4c6a-b8df-625e1435387a.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0069-0400-01 | EA - Each | 0069-0400 | d7c08308-f15a-4aba-9d7c-7c2716a206c1 | 1 | 2014-04-03 |
| 0069-0400-10 | EA - Each | 0069-0400 | e0653e4e-6e09-4e11-a661-10801d9d44eb | 1 | 2014-04-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| AZITHROMYCIN DIHYDRATE | ACTIVE INGREDIENT | 5FD1131I7S | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 7 | |
| AZITHROMYCIN ANHYDROUS | ACTIVE MOIETY | J2KLZ20U1M | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 7 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| azithromycin | AZITHROMYCIN | Lannett Company, Inc. | a2b0c06b-e93d-f5aa-e053-2995a90ac9aa | 2025-05-13 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | 47a8fd64-5a3d-490e-8ca8-5e6721c830cf | 2025-05-01 | Warnings, Adverse reactions | 5FD1131I7S |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Kesin Pharma Corporation | 3140f8fe-0644-7561-e063-6394a90a2c28 | 2025-04-21 | Adverse reactions | XF417D3PSL |
| azithromycin dihydrate | AZITHROMYCIN DIHYDRATE | Slate Run Pharmaceuticals, LLC | 33d4ac05-b564-440c-971d-b78590dd2c32 | 2025-04-17 | Warnings, Adverse reactions | 5FD1131I7S |
| Bio Co Enzyme Phase | ACONITICUM ACIDUM, CIS-, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ADRENALINUM, , ALPHA-KETOGLUTARICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, ASCORBICUM ACIDUM, BARIUM OXALSUCCINICUM, BETA VULGARIS, CERIUM OXALICUM, CITRICUM ACIDUM, CYSTEINUM, FUMARICUM ACIDUM, HEPAR SULPHURIS CALCAREUM, MAGNESIUM OROTICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM PHOSPHORICUM, NADIDUM, NATRUM OXALACETICUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PANTOTHENIC ACID, PROTEUS (MORGANI), PULSATILLA (PRATENSIS), PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, | Deseret Biologicals, Inc. | 6edee6eb-0ec9-4d2a-9dc9-dc2a6503a6db | 2025-04-08 | Warnings | XF417D3PSL |
| azithromycin | AZITHROMYCIN | Proficient Rx LP | 25bc2e78-9d0d-41c6-a55e-a267d4457967 | 2025-04-01 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | PD-Rx Pharmaceuticals, Inc. | e9800bbe-e8bf-4689-a8a5-dc23b5d2ee56 | 2025-03-26 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | TAGI Pharma, Inc. | 9f0501bf-d1c4-46a5-b253-3b9e61015e82 | 2025-03-07 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | TAGI Pharma, Inc. | 41e2163b-af61-4323-8b9c-2d44fc122fd9 | 2025-03-05 | Warnings, Adverse reactions | 5FD1131I7S |
| 87b9089f-c9cd-41c9-9358-29f6e4014af6 | 8d24bacb-feff-4c6a-b8df-625e1435387a | 2025-02-10 | Warnings, Adverse reactions | 87b9089f-c9cd-41c9-9358-29f6e4014af6 8d24bacb-feff-4c6a-b8df-625e1435387a | ||
| Azithromycin | AZITHROMYCIN MONOHYDRATE | Athenex Pharmaceutical Division, LLC. | 610a34ea-6aa7-4b94-a85a-ff16ca537d03 | 2025-01-28 | Warnings, Adverse reactions | 1668238 |
| Azithromycin | AZITHROMYCIN MONOHYDRATE | Athenex Pharmaceutical Division, LLC. | 324330c5-20fe-4b22-adf2-14a6e91e71ef | 2025-01-28 | Warnings, Adverse reactions | 1668238 |
| azithromycin dihydrate | AZITHROMYCIN DIHYDRATE | Coupler LLC | 2cc93e72-95ce-965b-e063-6394a90a8917 | 2025-01-28 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Coupler LLC | 2cc99fae-a72c-8893-e063-6394a90aa3ef | 2025-01-28 | Warnings, Adverse reactions | 5FD1131I7S |
| AZITHROMYCIN | AZITHROMYCIN | Direct_Rx | 8e6e11fb-eb9e-28ec-e053-2a95a90aa1a3 | 2025-01-22 | Warnings, Adverse reactions | 5FD1131I7S |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | AvPAK | fe070e2e-3e72-fb84-e053-6294a90afd88 | 2025-01-09 | Adverse reactions | XF417D3PSL |
| Azithromycin | AZITHROMYCIN | Zydus Lifesciences Limited | 0b63649d-558c-4250-90ee-af6e1e5c6d2c | 2025-01-09 | 5FD1131I7S | |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Proficient Rx LP | a8e106cb-7245-45a5-9aad-bd624b1e011d | 2025-01-01 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Advanced Rx Pharmacy of Tennessee, LLC | f1752913-85ac-01fa-e053-2995a90a2bd8 | 2024-12-31 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Advanced Rx of Tennessee, LLC | f1755cf3-bf7f-be40-e053-2a95a90a8536 | 2024-12-31 | Warnings, Adverse reactions | 5FD1131I7S |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.